Metabolic-Related Outcomes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Adults With Human Immunodeficiency Virus (HIV): A Multicenter Prospective Cohort Study
Javier Martínez‐Sanz(Instituto Cajal), Santiago Moreno(Hospital Universitario Ramón y Cajal), Sergio Serrano‐Villar, Antoni A Campins(Hospital Universitario Son Espases), Lucio García‐Fraile(Instituto de Salud Carlos III), Eva Orviz(Hospital Clínico San Carlos), Álvaro Mena de(Complexo Hospitalario Universitario A Coruña), Alfonso Muriel(Instituto Cajal)
Cited by 29
Related Papers
Meta-DiSc: a software for meta-analysis of test accuracy data
|BMC Medical Research Methodology|2006|1.9k
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel
|AIDS|2002|443
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort
|The Lancet HIV|2020|396
Mapping of the IgE and IgG4 sequential epitopes of milk allergens with a peptide microarray–based immunoassay
|Journal of Allergy and Clinical Immunology|2008|212
Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2006|137